Welcome to our dedicated page for HAPP news (Ticker: HAPP), a resource for investors and traders seeking the latest updates and insights on HAPP stock.
This page provides a historical news archive for Happiness Development Group Limited (HAPP) and its transition to Paranovus Entertainment Technology Ltd. Company press releases trace how HAPP evolved from a diversified business in nutraceutical and dietary supplements, e-commerce solutions and automobile sales into a renamed entity with a focus on entertainment and technology under the PAVS ticker.
Earlier news items under the HAPP symbol describe activities in its three main business lines, including developments in its nutraceutical and dietary supplement portfolio, initiatives in e-commerce services for small and medium-sized enterprises in China, and agreements related to automobile sales using a B2B model. These releases also cover corporate actions such as reverse share splits and Nasdaq notifications about minimum bid price compliance.
Later announcements under the Paranovus Entertainment Technology Ltd. name document the company’s strategic shift. They outline plans to enter a pan-entertainment field using technologies such as AI and describe a focus on AI-powered entertainment products, AI-driven games and applications, and TikTok-related e-commerce solutions through subsidiaries. Additional releases discuss the exit of legacy e-commerce, internet information, advertising and automobile sales businesses, as well as the acquisition of controlling equity interests in Bomie Wookoo Inc., a company offering e-commerce solutions.
Investors and researchers can use this news archive to follow the company’s corporate history, business transitions, and interactions with the Nasdaq Capital Market over time. For a complete view of the current business focus, more recent news under the PAVS symbol and Paranovus Entertainment Technology Ltd. name is particularly relevant.
Happiness Biotech Group Limited (Nasdaq: HAPP) announced a cooperation agreement between its subsidiary, Happy Buy, and Hive-Box, a leading parcel machine operation company. This partnership aims to enhance Happy Buy's fulfillment capabilities through Hive-Box's 24-hour self-service platform, catering to the growing community e-commerce sector in China. Hive-Box operates the world's largest express locker system, facilitating broader exposure and marketing for Happiness Biotech's dietary supplements. This collaboration marks a strategic step for Happy Buy as it seeks to expand within the e-commerce landscape.
Happiness Biotech Group Limited (Nasdaq: HAPP) has established a wholly owned subsidiary, Happy Buy Internet Technology Co., Ltd., to enhance its e-commerce initiatives. Targeting a B2B e-commerce model, Happy Buy aims to leverage the company's supply chain and sales advantages to increase product distribution. The company highlights successful e-commerce trials during the COVID-19 pandemic, leading to a strategic shift towards this model. Management plans to recruit experienced professionals to further develop this initiative, believing it will capitalize on Happiness Biotech's brand reputation.
Happiness Biotech Group Limited (Nasdaq: HAPP) has launched a new line of personal care products under the brand 'Cai Zhi Ning', targeting the elderly market. The product range includes Ganoderma lucidum essence oil, cleansing milk, shampoo, shower gel, and nourishing cream, capitalizing on the recognized benefits of Lucidum in China. Currently, the company operates 27 experience stores near tourist attractions, with plans to expand distribution online via platforms like Pinduoduo, Taobao, and JD.com. CEO Xuezhu Wang highlighted strong growth potential in the expanding personal care sector.
Happiness Biotech Group Limited (Nasdaq: HAPP) declared a cash dividend of $0.015 per ordinary share, scheduled for payment on August 17, 2020, to shareholders on record by August 10, 2020. Despite challenges posed by COVID-19 in the last fiscal quarter, the company reported stable operating conditions and healthy cash flow. CEO Xuezhu Wang expressed optimism for increasing shareholder returns once market conditions improve post-pandemic.
Happiness Biotech Group Limited (Nasdaq: HAPP) reported FY 2020 financial results, revealing a 1.8% revenue increase to $65,061,953 compared to $63,936,185 in FY 2019. Sales of Lucidum spore powder rose 42%, constituting 43.4% of total revenue. However, operating income fell 29.5% to $15,398,717, and net income dropped 32.2% to $12.69 million, largely due to increased selling expenses related to COVID-19 impacts. The company plans to strengthen online sales channels moving forward.
Happiness Biotech Group Limited (Nasdaq: HAPP) announced the successful acquisition of a Natural Product Number (NPN) license from Health Canada for its 75% Alcohol Disposable Hand Sanitizer. This milestone permits its hand sanitizer to be legally sold in Canada, with an initial order of 53,280 bottles shipped recently. The company previously exported 150,000 masks to Canada and received a second order for 200,000 units. CEO Xuezhu Wang emphasized that obtaining the NPN license demonstrates the quality of their products and indicates future export ambitions.
Happiness Biotech (Nasdaq: HAPP) announced it received CE certification for its COVID-19 antibody testing kits on June 5, 2020. The first batch of 10,000 kits is ready for shipment to European clients. The company is actively seeking approvals in more countries and has shipped samples to Uganda, Malaysia, and Canada. However, the CFDA's updated approval policy has delayed the approval process for new testing kits. The firm showcased its products at the Guangzhou International Anti-Epidemic Products Exhibition on June 10, highlighting its commitment to expanding its market presence.